300 related articles for article (PubMed ID: 31303557)
1. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study.
Wang L; Krebs E; Min JE; Mathews WC; Nijhawan A; Somboonwit C; Aberg JA; Moore RD; Gebo KA; Nosyk B;
Lancet HIV; 2019 Aug; 6(8):e531-e539. PubMed ID: 31303557
[TBL] [Abstract][Full Text] [Related]
2. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
[TBL] [Abstract][Full Text] [Related]
3. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
[TBL] [Abstract][Full Text] [Related]
4. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
5. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
[TBL] [Abstract][Full Text] [Related]
7. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
Zalla LC; Cole SR; Eron JJ; Adimora AA; Vines AI; Althoff KN; Silverberg MJ; Horberg MA; Marconi VC; Coburn SB; Lang R; Williams EC; Gill MJ; Gebo KA; Klein M; Sterling TR; Rebeiro PF; Mayor AM; Moore RD; Edwards JK
JAMA; 2023 Jan; 329(1):52-62. PubMed ID: 36594946
[TBL] [Abstract][Full Text] [Related]
8. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
10. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
Osler M; Cornell M; Ford N; Hilderbrand K; Goemaere E; Boulle A
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25530. PubMed ID: 32589367
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.
Gwynn RC; Fawzy A; Viho I; Wu Y; Abrams EJ; Nash D
BMC Health Serv Res; 2015 Jun; 15():247. PubMed ID: 26108273
[TBL] [Abstract][Full Text] [Related]
12. Modelling immune deterioration, immune recovery and state-specific duration of HIV-infected women with viral load adjustment: using parametric multistate model.
Dessie ZG; Zewotir T; Mwambi H; North D
BMC Public Health; 2020 Mar; 20(1):416. PubMed ID: 32228523
[TBL] [Abstract][Full Text] [Related]
13. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.
Rebeiro PF; Abraham AG; Horberg MA; Althoff KN; Yehia BR; Buchacz K; Lau BM; Sterling TR; Gange SJ
AIDS Patient Care STDS; 2017 Mar; 31(3):129-144. PubMed ID: 28282246
[TBL] [Abstract][Full Text] [Related]
14. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
[TBL] [Abstract][Full Text] [Related]
15. Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort study.
Ibiloye O; Jwanle P; Masquillier C; Van Belle S; Jaachi E; Amoo O; Isah A; Omole T; Samuel JO; van Olmen J; Lynen L; Okonkwo P; Decroo T
PLoS One; 2021; 16(11):e0260557. PubMed ID: 34847194
[TBL] [Abstract][Full Text] [Related]
16. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
[TBL] [Abstract][Full Text] [Related]
17. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
[TBL] [Abstract][Full Text] [Related]
18. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
[TBL] [Abstract][Full Text] [Related]
19. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
[TBL] [Abstract][Full Text] [Related]
20. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
